Cargando…
Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study
BACKGROUND: Hospital-acquired thrombosis (HAT) is a leading cause of preventable death and disability worldwide. HAT includes any venous thromboembolic (VTE) event occurring in-hospital or within 90-days of hospitalisation. Despite availability of evidence-based guidelines for HAT risk assessment an...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366250/ https://www.ncbi.nlm.nih.gov/pubmed/37074512 http://dx.doi.org/10.1007/s11096-023-01578-w |
_version_ | 1785077126923288576 |
---|---|
author | Kemp, Megan Chan, Amy Hai Yan Harrison, Jeff Rogers, Hannah Zhao, Adele Kaur, Harleen Tang, Genevieve Yang, Esther Beyene, Kebede |
author_facet | Kemp, Megan Chan, Amy Hai Yan Harrison, Jeff Rogers, Hannah Zhao, Adele Kaur, Harleen Tang, Genevieve Yang, Esther Beyene, Kebede |
author_sort | Kemp, Megan |
collection | PubMed |
description | BACKGROUND: Hospital-acquired thrombosis (HAT) is a leading cause of preventable death and disability worldwide. HAT includes any venous thromboembolic (VTE) event occurring in-hospital or within 90-days of hospitalisation. Despite availability of evidence-based guidelines for HAT risk assessment and prophylaxis, guidelines are still underutilised. AIM: To determine the proportion of patients who developed HAT that could have been potentially prevented with appropriate VTE risk assessment and prophylaxis at a large public hospital in New Zealand. Additionally, the predictors of VTE risk assessment and thromboprophylaxis were examined. METHOD: VTE patients admitted under general medicine, reablement, general surgery, or orthopaedic surgery service were identified using ICD-10-AM codes. Data were collected on patient characteristics, VTE risk factors, and the thromboprophylaxis regimen prescribed. The hospital VTE guidelines were used to determine rates of VTE risk assessment and the appropriateness of thromboprophylaxis. RESULTS: Of 1302 VTE patients, 213 HATs were identified. Of these, 116 (54%) received VTE risk assessment, and 98 (46%) received thromboprophylaxis. Patients who received VTE risk assessment were 15 times more likely to receive thromboprophylaxis (odds ratio [OR] = 15.4; 95% CI 7.65–30.98) and 2.8 times more likely to receive appropriate thromboprophylaxis (OR = 2.79; 95% CI 1.59–4.89). CONCLUSION: A large proportion of high-risk patients who were admitted to medical, general surgery and reablement services and who developed HAT did not receive VTE risk assessment and thromboprophylaxis during their index admission, demonstrating a significant gap between guideline recommendations and clinical practice. Implementing mandatory VTE risk assessment and adherence to guidelines to improve thromboprophylaxis prescription in hospitalised patients may help reduce the burden of HAT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11096-023-01578-w. |
format | Online Article Text |
id | pubmed-10366250 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-103662502023-07-26 Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study Kemp, Megan Chan, Amy Hai Yan Harrison, Jeff Rogers, Hannah Zhao, Adele Kaur, Harleen Tang, Genevieve Yang, Esther Beyene, Kebede Int J Clin Pharm Research Article BACKGROUND: Hospital-acquired thrombosis (HAT) is a leading cause of preventable death and disability worldwide. HAT includes any venous thromboembolic (VTE) event occurring in-hospital or within 90-days of hospitalisation. Despite availability of evidence-based guidelines for HAT risk assessment and prophylaxis, guidelines are still underutilised. AIM: To determine the proportion of patients who developed HAT that could have been potentially prevented with appropriate VTE risk assessment and prophylaxis at a large public hospital in New Zealand. Additionally, the predictors of VTE risk assessment and thromboprophylaxis were examined. METHOD: VTE patients admitted under general medicine, reablement, general surgery, or orthopaedic surgery service were identified using ICD-10-AM codes. Data were collected on patient characteristics, VTE risk factors, and the thromboprophylaxis regimen prescribed. The hospital VTE guidelines were used to determine rates of VTE risk assessment and the appropriateness of thromboprophylaxis. RESULTS: Of 1302 VTE patients, 213 HATs were identified. Of these, 116 (54%) received VTE risk assessment, and 98 (46%) received thromboprophylaxis. Patients who received VTE risk assessment were 15 times more likely to receive thromboprophylaxis (odds ratio [OR] = 15.4; 95% CI 7.65–30.98) and 2.8 times more likely to receive appropriate thromboprophylaxis (OR = 2.79; 95% CI 1.59–4.89). CONCLUSION: A large proportion of high-risk patients who were admitted to medical, general surgery and reablement services and who developed HAT did not receive VTE risk assessment and thromboprophylaxis during their index admission, demonstrating a significant gap between guideline recommendations and clinical practice. Implementing mandatory VTE risk assessment and adherence to guidelines to improve thromboprophylaxis prescription in hospitalised patients may help reduce the burden of HAT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11096-023-01578-w. Springer International Publishing 2023-04-19 2023 /pmc/articles/PMC10366250/ /pubmed/37074512 http://dx.doi.org/10.1007/s11096-023-01578-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Kemp, Megan Chan, Amy Hai Yan Harrison, Jeff Rogers, Hannah Zhao, Adele Kaur, Harleen Tang, Genevieve Yang, Esther Beyene, Kebede Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study |
title | Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study |
title_full | Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study |
title_fullStr | Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study |
title_full_unstemmed | Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study |
title_short | Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study |
title_sort | formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366250/ https://www.ncbi.nlm.nih.gov/pubmed/37074512 http://dx.doi.org/10.1007/s11096-023-01578-w |
work_keys_str_mv | AT kempmegan formalandinformalvenousthromboembolismriskassessmentandimpactonprescribingofthromboprophylaxisaretrospectivecohortstudy AT chanamyhaiyan formalandinformalvenousthromboembolismriskassessmentandimpactonprescribingofthromboprophylaxisaretrospectivecohortstudy AT harrisonjeff formalandinformalvenousthromboembolismriskassessmentandimpactonprescribingofthromboprophylaxisaretrospectivecohortstudy AT rogershannah formalandinformalvenousthromboembolismriskassessmentandimpactonprescribingofthromboprophylaxisaretrospectivecohortstudy AT zhaoadele formalandinformalvenousthromboembolismriskassessmentandimpactonprescribingofthromboprophylaxisaretrospectivecohortstudy AT kaurharleen formalandinformalvenousthromboembolismriskassessmentandimpactonprescribingofthromboprophylaxisaretrospectivecohortstudy AT tanggenevieve formalandinformalvenousthromboembolismriskassessmentandimpactonprescribingofthromboprophylaxisaretrospectivecohortstudy AT yangesther formalandinformalvenousthromboembolismriskassessmentandimpactonprescribingofthromboprophylaxisaretrospectivecohortstudy AT beyenekebede formalandinformalvenousthromboembolismriskassessmentandimpactonprescribingofthromboprophylaxisaretrospectivecohortstudy |